Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 10
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
ALPHAEON Enters into Agreement with NovaBay Pharma 13
NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14
NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15
Licensing Agreements 16
NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 16
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 17
Equity Offering 18
NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 18
NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 19
NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 20
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 21
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 22
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 23
NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 24
NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 26
NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 27
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 28
NovaBay Pharma Completes Public Offering Of Shares For US$7 Million 29
NovaBay Pharma Completes Registered Direct Offering Of US$5.16 Million 30
Acquisition 32
Jinzi Ham to Acquire 37.14% Stake in NovaBay Pharma for USD27.06 Million 32
NovaBay Pharmaceuticals Inc – Key Competitors 33
NovaBay Pharmaceuticals Inc – Key Employees 34
NovaBay Pharmaceuticals Inc – Locations And Subsidiaries 35
Head Office 35
Recent Developments 36
Financial Announcements 36
Nov 14, 2017: NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results 36
Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results 38
May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results 40
Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance 42
Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016 44
Nov 10, 2016: NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results 45
Aug 11, 2016: NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results 47
May 12, 2016: NovaBay Pharmaceuticals Reports 2016 First Quarter Financial Results 49
Mar 03, 2016: NovaBay Pharmaceuticals Reports 2015 Fourth Quarter and Full Year Financial Results 51
Corporate Communications 53
Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition 53
Oct 31, 2016: NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements 54
Jun 13, 2016: NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek President and Chief Executive Officer 55
May 09, 2016: NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors 56
Other Significant Developments 57
Jan 11, 2016: NovaBay Pharmaceuticals Expects Fourth Quarter 2015 Avenova Sales to Exceed $1.5 Million 57
Jan 07, 2016: NovaBay Pharmaceuticals Secures $3 Million Bridge Loan 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NovaBay Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9
NovaBay Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 10
NovaBay Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
ALPHAEON Enters into Agreement with NovaBay Pharma 13
NovaBay Pharma Enters into Distribution Agreement with Cardinal Health for Avenova 14
NovaBay Pharma Enters into Distribution Agreement with Biopharm for NeutroPhase 15
NovaBay Pharma Enters Into Licensing Agreement With China Pioneer Pharma For CelleRx And i-Lid Cleanser 16
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 17
NovaBay Pharma Raises USD0.9 Million in Private Placement of Shares upon Exercise of Warrants 18
NovaBay Pharma Raises USD7 Million in Private Placement of Shares upon Exercise of Warrants 19
NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares upon Exercise of Warrants 20
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 21
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 22
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 23
NovaBay Pharma Raises USD2.5 Million in Public Offering of Shares 24
NovaBay Pharma Raises USD6.9 Million in Private Placement of Shares and Warrants 26
NovaBay Pharma Raises USD4.7 Million in Private Placement of Units 27
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 28
NovaBay Pharma Completes Public Offering Of Shares For US$7 Million 29
NovaBay Pharma Completes Registered Direct Offering Of US$5.16 Million 30
Jinzi Ham to Acquire 37.14% Stake in NovaBay Pharma for USD27.06 Million 32
NovaBay Pharmaceuticals Inc, Key Competitors 33
NovaBay Pharmaceuticals Inc, Key Employees 34
【免責事項】
http://www.globalresearch.jp/disclaimer